Myasthenia Gravis Immunology
Mostrando 1-2 de 2 artigos, teses e dissertações.
-
1. Influência da terapêutica sobre a qualidade de vida do paciente com miastenia gravis / The influence of therapeutics on the quality of life of Myasthenia gravis patients
INTRODUCTION: Myasthenia gravis (MG) is an immune mediated disease with production of antibodies against post-synaptic acetylcholine receptor of neuromuscular junctions (AAChR,Musk) and orders in nervous impulse transmission. The disease´s clinical characteristics include fatigability and fluctuating weakness of voluntary muscles. Acetylcholinesterase inhib
Publicado em: 2006
-
2. Deficiencies in anti-acetylcholine receptor antibody measurement in myasthenia gravis.
In a retrospective case note study of 86 patients with myasthenia gravis, 60 had an anti-acetylcholine receptor antibody assay performed by the regional immunology laboratory. Antibody was detected in 38% which compares with 66-93% in other series. Whilst the use of staphylococcal protein A to precipitate the antibody-receptor complex, rather than anti-human